Regeneron Announces Upcoming Investor Conference Presentations

Date : 10/18/2019 @ 12:30PM
Source : PR Newswire (US)
Stock : Regeneron Pharmaceuticals Inc (REGN)
Quote : 344.87  6.48 (1.91%) @ 12:59AM
After Hours
Last Trade
Last $ 344.87 ◊ 0.00 (0.00%)

Regeneron Announces Upcoming Investor Conference Presentations

Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart

1 Month : From Oct 2019 to Nov 2019

Click Here for more Regeneron Pharmaceuticals Charts.

TARRYTOWN, N.Y., Oct. 18, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations as follows:

  • Credit Suisse 28th Annual Healthcare Conference at 10:00 a.m. EST (8:00 a.m. MST) on Tuesday, November 12, 2019
  • Jefferies 2019 London Healthcare Conference at 9:00 a.m. EST (2:00 p.m. GMT) on Wednesday, November 20, 2019

The sessions may be accessed from the "Investors & Media" page of Regeneron's website at http://investor.regeneron.com/events-and-presentations. Replays of the webcasts will be archived on the Company's website.

About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.

Regeneron is accelerating and improving the traditional drug development process through its proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.

Contact Information:
Investor Relations
Justin Holko
914.847.7786
justin.holko@regeneron.com

Corporate Communications
Hala Mirza
914.847.3422
hala.mirza@regeneron.com

Cision View original content:http://www.prnewswire.com/news-releases/regeneron-announces-upcoming-investor-conference-presentations-300941158.html

SOURCE Regeneron Pharmaceuticals, Inc.

Copyright 2019 PR Newswire

Latest REGN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.